Related Experiment Video
Updated: Apr 15, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination
Mi Na Kim1, Kwang-Hyub Han2, Sang Hoon Ahn2
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Insights
Preventing liver cancer from chronic hepatitis B (CHB) involves vaccination, antiviral therapies to suppress viral replication, and regular screening. Early detection and treatment are key to improving outcomes for hepatocellular carcinoma (HCC).
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Chronic hepatitis B (CHB) is a leading cause of hepatocellular carcinoma (HCC), responsible for about 50% of cases.
- Hepatitis B virus (HBV) infection poses a significant global health burden, necessitating effective prevention strategies.
Purpose of the Study:
- To review primary, secondary, and tertiary preventive measures against HBV-related HCC.
- To highlight the importance of vaccination, antiviral treatments, and surveillance in HCC prevention.
Main Methods:
- Literature review of primary, secondary, and tertiary prevention strategies for HBV-related HCC.
- Analysis of the efficacy of vaccination, antiviral therapies (interferon, nucleos(t)ide analogs), and surveillance methods.
Main Results:
- Universal hepatitis B vaccination is the most effective primary prevention method, significantly reducing HBV infection and HCC rates.
- Antiviral treatments and suppression of HBV DNA levels are crucial for preventing progression to cirrhosis and HCC.
- Periodic surveillance (ultrasonography, α-fetoprotein) aids early HCC detection for curative treatment.
- Adjuvant interferon prevents early recurrence post-resection, while nucleos(t)ide analogs show promise for late recurrence prevention through viral suppression.
Conclusions:
- A multi-faceted approach including vaccination, antiviral therapy, and surveillance is essential for preventing HBV-related HCC.
- Optimal preventive strategies require further investigation to address early and late recurrence effectively.
Abstract:
Chronic hepatitis B (CHB) infection is the major cause of hepatocellular carcinoma (HCC), accounting for approximately 50% of the underlying etiologies. We reviewed the primary, secondary, and tertiary measures for the prevention of hepatitis B virus (HBV)-related HCC. The most effective method for preventing HBV-related HCC is vaccination. Universal hepatitis B vaccination has been shown to reduce the rates of HBV infection and HCC significantly. Once chronic HBV infection is established, antiviral treatment using interferon or nucleos(t)ide analogs is used to prevent disease progression to cirrhosis, HCC, or both. Studies have found viral replication indicated by HBV DNA level to be a strong risk factor for development of HCC. Additionally, periodic surveillance using ultrasonography and serum α-fetoprotein for earlier detection of HCC is also important so that curative treatments with survival benefit can be possible. Finally, adjuvant antiviral treatment using interferon or nucleos(t)ide analogs is used to prevent tumor recurrence after curative resection. Adjuvant interferon treatment prevented early recurrence, not late recurrence, probably due to its antiangiogenetic and antiproliferative effects. Adjuvant nucleos(t)ide analogs demonstrated promising results for preventing late recurrence, probably due to effective suppression of viral replication. Further investigations are required to establish the optimal preventive plans for HBV-related HCC.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Cancer Prevention
Some...
Cancer Prevention
Preventive Healthcare Services
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...